Rinvatercept

Rinvatercept, a fusion protein, is a glycyl (1) -chimeric N-terminal (1-108) -peptide (2-109) combined from the sequences of the extracellular domains of the human ACVR2A/B, and is fused via a G3 peptide linker (110-112) to an immunoglobulin G1 (IgG1) Fc fragment. Rinvatercept can be used for research of neuromuscular disease[1].